Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Appointment of Matthew Pauls to its Board of Directors

Fri, Sep 04, 2015 19:01 CET

September 4, 2015 – Dublin, Ireland and Trevose, Pa., USA – Strongbridge Biopharma plc, formerly known as Cortendo plc, (the “Company”), announced today that Matthew Pauls, president and chief executive officer of Strongbridge Biopharma plc, has been appointed to the Company’s Board of Directors. Mr. Pauls’s appointment as a director is effective immediately. The Company also announced that Eigil Stray Spetalen, who has served as a director and previously as chairman of Cortendo AB, has elected to step down from the Cortendo AB Board of Directors. “We are pleased to welcome Matt to

Cortendo plc Changes Name to Strongbridge Biopharma plc

Fri, Sep 04, 2015 18:31 CET

Dublin, Ireland and Trevose, Pa., USA – September 4, 2015 – Cortendo plc announced today that the Company has changed its name to Strongbridge Biopharma plc. Strongbridge Biopharma will become effective immediately and the new logo and corporate branding elements will be rolled out in the near future. Under the new corporate name, Strongbridge Biopharma will remain committed to building a biopharmaceutical company focused on the development, in-licensing, acquisition and eventual commercialization of complementary product candidates across multiple franchises that target rare diseases.

Cortendo plc Announces Reverse Share Split

Fri, Sep 04, 2015 16:30 CET

September 4, 2015 – Dublin, Ireland and Trevose, Pa., USA – Cortendo plc today announced that immediately following the settlement of its exchange offer to acquire any and all issued ordinary shares of Cortendo AB (publ), it will effect a 1-for-11 reverse share split of its ordinary shares. On or about September 8, 2015, each 11 shares of the Company’s issued and outstanding ordinary shares will be converted into 1 ordinary share. Beneficial interests in the shares (in the form of depositary receipts) will begin trading on the NOTC on a split-adjusted basis on or about September 9, 2015.